Introduction
Autoimmune diseases
Autoantibodies - Introduction
Autoantibodies - Determination
 
Autoantibodies
Rheumatoid Factor
Antinuclear Antibodies (ANA)
Specific Antibodies
Anti-neutrophil Cytoplasmic Antibodies
(ANCA)
Anti-phospholipid Antibodies
Anti-mitochondrial Antibodies (AMA)
Anti-endothelial Cell Antibodies (AECA)
Anti CCP antibodies
Antibodies against DNases
 
Quality Assurance
 
Reference ranges
 
Algorithm
ANA and incidence of diseases
Proposed stepwise diagnosis scheme
Positive Immunoflourescence -
Nucleoplasmic
Positive Immunoflourescence - Nucleolar
Positive Immunoflourescence -
Cytoplasmic
Type of autoimmune diseases
Conditions associated with antinuclear
antibodies (ANA)
 
Slide show
 
References
 
Collaborators
Anti-mitochondrial Antibodies (AMA) - Clinical significance


1) Physiologic changes in the concentration of anti-mitochondrial antibodies (AMA)
2) Pathologic changes in the concentration anti-mitochondrial antibodies (AMA)
a) Increased anti-mitochondrial antibodies (AMA) in:
Autoimmune hepatitis
Primary biliary cirrhosis
Chronic active hepatitis
Cirrhosis of liver
Oxic hepatitis
SLE
Sjögren’s syndrome

Reference values
dependent on method

Immunofluorescence method.

negative

ELISA

 

 

Units

negative

< 10

U/ml

positive

> 10

U/ml